Most Clicked StoriesMore >


Neurologists release new guidelines for use of narcotic pain medication

American Pain Society SmartBrief | Oct 01, 2014

The American Academy of Neurology issued new guidelines outlining how to safely and effectively prescribe narcotic pain drugs. In a statement published in the journal Neurology, the group urged physicians to contact a pain management specialist if a patient's daily dose of opioid pain drugs reaches between 80 milligrams and 120 milligrams, particularly if the patient shows no signs of significant improvement. The risks of using opioid pain drugs for chronic headaches, fibromyalgia and low back pain surpass their benefits, the group said. HealthDay News (09/29)


5-year study to look at alternative therapies for chronic pain

American Pain Society SmartBrief | Oct 01, 2014

Study questions use of cutoffs with visual pain scores

American Pain Society SmartBrief | Oct 15, 2014

Study supports injections for treating chronic lower back pain

American Pain Society SmartBrief | Oct 22, 2014

Opioid alternative shows promise in clinical trials

American Pain Society SmartBrief | Oct 29, 2014

Chronic-pain patients pay more attention to pain-related words

American Pain Society SmartBrief | Oct 08, 2014

FDA to give 3rd opioid drug its abuse-deterrent label

American Pain Society SmartBrief | Oct 22, 2014

FDA issues draft guidance on development of migraine drugs

American Pain Society SmartBrief | Oct 22, 2014

Theramine may reduce lower back pain, inflammation, study says

American Pain Society SmartBrief | Oct 08, 2014

Lidocaine may have post-mastectomy pain benefits, study says

American Pain Society SmartBrief | Oct 15, 2014


Find American Pain Society SmartBrief Issues by Date:





Sign up for American Pain Society SmartBrief



Designed specifically for the pain professional, the APS SmartBrief is a FREE, weekly e-mail newsletter. By providing the latest need-to-know industry news and information, APS SmartBrief saves you time and keeps you smart. Learn more